Search
Now showing items 1-10 of 66
Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia
Claus, Rainer et al. (2012)
Wissenschaftlicher Artikel
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis
Benner, Axel et al. (2014)
Wissenschaftlicher Artikel
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
Maurer, Christian et al. (2016)
Wissenschaftlicher Artikel
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert, Andreas et al. (2016)
Wissenschaftlicher Artikel
Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
Idler, Irina et al. (2010)
Wissenschaftlicher Artikel
Immune modulatory agents in hematopoietic malignancies
Idler, Irina et al. (2011)
Wissenschaftlicher Artikel
Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
Fink, Anna Maria et al. (2017)
Wissenschaftlicher Artikel
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
Langerbeins, Petra et al. (2014)
Wissenschaftlicher Artikel
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)
Philippen, Angela et al. (2010)
Wissenschaftlicher Artikel
Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
Goebel, Maria et al. (2013)
Wissenschaftlicher Artikel